Skip to main navigation Skip to search Skip to main content

Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation

Project: Research

Project Details

StatusActive
Effective start/end date05/10/23 → 04/2/27

Funding

  • Novo Nordisk Incorporated: $2,520.00